Copyright Reports & Markets. All rights reserved.

Global Pomalidomide Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Request for Sample of this report
Buy now

Table of Contents

    1 Market Overview

    • 1.1 Pomalidomide Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 1mg Tables
      • 1.2.2 2mg Tables
      • 1.2.3 4mg Tables
    • 1.3 Market Analysis by Applications
      • 1.3.1 Hospital
      • 1.3.2 Drug Center
      • 1.3.3 Clinic
      • 1.3.4 Other
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Celgene
      • 2.1.1 Business Overview
      • 2.1.2 Pomalidomide Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Celgene Pomalidomide Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Natco Pharma
      • 2.2.1 Business Overview
      • 2.2.2 Pomalidomide Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Natco Pharma Pomalidomide Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Intas Pharmaceuticals
      • 2.3.1 Business Overview
      • 2.3.2 Pomalidomide Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Intas Pharmaceuticals Pomalidomide Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Indiabulls Pharmaceutical
      • 2.4.1 Business Overview
      • 2.4.2 Pomalidomide Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Indiabulls Pharmaceutical Pomalidomide Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Cipla
      • 2.5.1 Business Overview
      • 2.5.2 Pomalidomide Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Cipla Pomalidomide Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Glenmark Pharmaceuticals
      • 2.6.1 Business Overview
      • 2.6.2 Pomalidomide Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Glenmark Pharmaceuticals Pomalidomide Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Dr Reddy's Laboratories
      • 2.7.1 Business Overview
      • 2.7.2 Pomalidomide Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Dr Reddy's Laboratories Pomalidomide Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Qilu Pharmaceutical
      • 2.8.1 Business Overview
      • 2.8.2 Pomalidomide Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Qilu Pharmaceutical Pomalidomide Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Chia Tai-Tianqing
      • 2.9.1 Business Overview
      • 2.9.2 Pomalidomide Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Chia Tai-Tianqing Pomalidomide Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 Hanson Pharm
      • 2.10.1 Business Overview
      • 2.10.2 Pomalidomide Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Hanson Pharm Pomalidomide Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.11 Meidakang Huakang Pharmaceutical
      • 2.11.1 Business Overview
      • 2.11.2 Pomalidomide Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 Meidakang Huakang Pharmaceutical Pomalidomide Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.12 Shandong Kongfu Pharmaceutical
      • 2.12.1 Business Overview
      • 2.12.2 Pomalidomide Type and Applications
        • 2.12.2.1 Product A
        • 2.12.2.2 Product B
      • 2.12.3 Shandong Kongfu Pharmaceutical Pomalidomide Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.13 SL PHARM
      • 2.13.1 Business Overview
      • 2.13.2 Pomalidomide Type and Applications
        • 2.13.2.1 Product A
        • 2.13.2.2 Product B
      • 2.13.3 SL PHARM Pomalidomide Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Pomalidomide Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Pomalidomide Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Pomalidomide Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Pomalidomide Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Pomalidomide Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Pomalidomide Market Analysis by Regions

    • 4.1 Global Pomalidomide Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Pomalidomide Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Pomalidomide Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Pomalidomide Sales and Growth Rate (2014-2019)
    • 4.3 Europe Pomalidomide Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Pomalidomide Sales and Growth Rate (2014-2019)
    • 4.5 South America Pomalidomide Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Pomalidomide Sales and Growth Rate (2014-2019)

    5 North America Pomalidomide by Country

    • 5.1 North America Pomalidomide Sales, Revenue and Market Share by Country
      • 5.1.1 North America Pomalidomide Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Pomalidomide Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Pomalidomide Sales and Growth Rate (2014-2019)
    • 5.3 Canada Pomalidomide Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Pomalidomide Sales and Growth Rate (2014-2019)

    6 Europe Pomalidomide by Country

    • 6.1 Europe Pomalidomide Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Pomalidomide Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Pomalidomide Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Pomalidomide Sales and Growth Rate (2014-2019)
    • 6.3 UK Pomalidomide Sales and Growth Rate (2014-2019)
    • 6.4 France Pomalidomide Sales and Growth Rate (2014-2019)
    • 6.5 Russia Pomalidomide Sales and Growth Rate (2014-2019)
    • 6.6 Italy Pomalidomide Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Pomalidomide by Country

    • 7.1 Asia-Pacific Pomalidomide Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Pomalidomide Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Pomalidomide Revenue and Market Share by Country (2014-2019)
    • 7.2 China Pomalidomide Sales and Growth Rate (2014-2019)
    • 7.3 Japan Pomalidomide Sales and Growth Rate (2014-2019)
    • 7.4 Korea Pomalidomide Sales and Growth Rate (2014-2019)
    • 7.5 India Pomalidomide Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Pomalidomide Sales and Growth Rate (2014-2019)

    8 South America Pomalidomide by Country

    • 8.1 South America Pomalidomide Sales, Revenue and Market Share by Country
      • 8.1.1 South America Pomalidomide Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Pomalidomide Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Pomalidomide Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Pomalidomide Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Pomalidomide Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Pomalidomide by Countries

    • 9.1 Middle East and Africa Pomalidomide Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Pomalidomide Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Pomalidomide Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Pomalidomide Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Pomalidomide Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Pomalidomide Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Pomalidomide Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Pomalidomide Sales and Growth Rate (2014-2019)

    10 Global Pomalidomide Market Segment by Type

    • 10.1 Global Pomalidomide Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Pomalidomide Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Pomalidomide Revenue and Market Share by Type (2014-2019)
    • 10.2 1mg Tables Sales Growth and Price
      • 10.2.1 Global 1mg Tables Sales Growth (2014-2019)
      • 10.2.2 Global 1mg Tables Price (2014-2019)
    • 10.3 2mg Tables Sales Growth and Price
      • 10.3.1 Global 2mg Tables Sales Growth (2014-2019)
      • 10.3.2 Global 2mg Tables Price (2014-2019)
    • 10.4 4mg Tables Sales Growth and Price
      • 10.4.1 Global 4mg Tables Sales Growth (2014-2019)
      • 10.4.2 Global 4mg Tables Price (2014-2019)

    11 Global Pomalidomide Market Segment by Application

    • 11.1 Global Pomalidomide Sales Market Share by Application (2014-2019)
    • 11.2 Hospital Sales Growth (2014-2019)
    • 11.3 Drug Center Sales Growth (2014-2019)
    • 11.4 Clinic Sales Growth (2014-2019)
    • 11.5 Other Sales Growth (2014-2019)

    12 Pomalidomide Market Forecast (2019-2024)

    • 12.1 Global Pomalidomide Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Pomalidomide Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Pomalidomide Market Forecast (2019-2024)
      • 12.2.2 Europe Pomalidomide Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Pomalidomide Market Forecast (2019-2024)
      • 12.2.4 South America Pomalidomide Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Pomalidomide Market Forecast (2019-2024)
    • 12.3 Pomalidomide Market Forecast by Type (2019-2024)
      • 12.3.1 Global Pomalidomide Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Pomalidomide Market Share Forecast by Type (2019-2024)
    • 12.4 Pomalidomide Market Forecast by Application (2019-2024)
      • 12.4.1 Global Pomalidomide Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Pomalidomide Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Scope of the Report:
      The worldwide market for Pomalidomide is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
      This report focuses on the Pomalidomide in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

      Market Segment by Manufacturers, this report covers
      Celgene
      Natco Pharma
      Intas Pharmaceuticals
      Indiabulls Pharmaceutical
      Cipla
      Glenmark Pharmaceuticals
      Dr Reddy's Laboratories
      Qilu Pharmaceutical
      Chia Tai-Tianqing
      Hanson Pharm
      Meidakang Huakang Pharmaceutical
      Shandong Kongfu Pharmaceutical
      SL PHARM

      Market Segment by Regions, regional analysis covers
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      South America (Brazil, Argentina, Colombia etc.)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers
      1mg Tables
      2mg Tables
      4mg Tables

      Market Segment by Applications, can be divided into
      Hospital
      Drug Center
      Clinic
      Other

      The content of the study subjects, includes a total of 15 chapters:
      Chapter 1, to describe Pomalidomide product scope, market overview, market opportunities, market driving force and market risks.
      Chapter 2, to profile the top manufacturers of Pomalidomide, with price, sales, revenue and global market share of Pomalidomide in 2017 and 2018.
      Chapter 3, the Pomalidomide competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
      Chapter 4, the Pomalidomide breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
      Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
      Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
      Chapter 12, Pomalidomide market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
      Chapter 13, 14 and 15, to describe Pomalidomide sales channel, distributors, customers, research findings and conclusion, appendix and data source.

      Buy now